Lawmakers should take their earliest opportunity to give small-molecule drugs the same 13-year exemption as biologics, and allow multi-use orphan drugs to keep their exemption as well.
The University of Missouri Research Reactor (MURR) has successfully delivered its first batch of no-carrier-added lutetium-177 (NCA Lu-177) for cancer treatment
Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) s lead compound PTX-100 is potentially a significant future treatment for T-Cell Lymphoma, according to a.
Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.